Latest Safety News

Argenica Therapeutics has received detailed FDA feedback outlining specific data requirements to lift the clinical hold on its ARG-007 stroke trial in the US, setting a clear path forward for its neuroprotective drug.

Noble Helium has launched a rigorously vetted five-hole drilling campaign targeting a 225.5 BCF helium resource in Tanzania’s North Rukwa Project, aiming for near-term cash flow with reduced costs and enhanced geological insight.

Orora Limited reported solid FY25 financial results driven by strong performance in its Cans business and the Saverglass acquisition, alongside key capacity expansions and glass network optimizations. The company’s robust balance sheet supports ongoing shareholder returns and a positive outlook for FY26.

Ventia Services Group has upgraded its FY25 profit guidance following a strong first half marked by record contract wins and an expanded share buyback program.

Orora Limited reported a 24.4% increase in FY25 revenue to A$2.09 billion, marking the completion of its strategic portfolio reshaping with the sale of its North American packaging business. The company advances sustainability targets while maintaining steady dividends and a share buyback program.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.

New Zealand Coastal Seafoods Limited has completed a major vessel upgrade, attracted international investment, and is preparing to resume ASX trading after strategic corporate changes.

Evolution Mining has delivered a landmark FY25 with record profits and cash flow, tripling its final dividend, while setting a stable production and cost outlook for FY26 amid ongoing project developments and sustainability commitments.

AGL Energy Limited posted a statutory loss of $98 million for FY25, while underlying profit declined 21.2% to $640 million. The company reaffirmed its commitment to a renewable energy transition with a 9.6 GW development pipeline and declared a fully franked final dividend of 25 cents per share.

Evolution Mining Limited has reported a landmark FY25 with statutory net profit soaring 119% to $926.2 million and record gold and copper output across its portfolio. Key projects like Mungari’s mill expansion and Cowal’s open pit extension are progressing ahead of schedule, underpinning a confident outlook.

Amotiv Limited reported a modest 1% revenue increase to $997.4 million in FY25 but posted a net loss of $106.3 million, driven by a significant $200.4 million impairment. The company declared a fully franked final dividend of 22 cents per share and outlined strategic initiatives to navigate ongoing market challenges.

Recce Pharmaceuticals’ RECCE 327 Topical Gel shows statistically significant superiority over standard antibiotics in treating antibiotic-resistant burn wounds in preclinical models, advancing its U.S. Department of Defense collaboration.